These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 6976436)

  • 1. Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.
    Stanbury SW
    J R Coll Physicians Lond; 1981 Oct; 15(4):205-9, 212-7. PubMed ID: 6976436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ; Langman CB; Favus MJ
    Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxy vitamin D.
    Fuss M; Cogan E; Gillet C; Karmali R; Geurts J; Bergans A; Brauman H; Bouillon R; Corvilain J
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):807-15. PubMed ID: 3874724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperparathyroidism in chronic renal failure. Assessment of autonomy by plasma-parathyroid-hormone response to alterations in calcium.
    Buckle RM
    Lancet; 1970 Aug; 2(7666):234-7. PubMed ID: 4193689
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism.
    Taylor AV; Wise PH
    Postgrad Med J; 1997 Dec; 73(866):813-5. PubMed ID: 9497953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
    Takamoto S; Onishi T; Morimoto S; Imanaka S; Tsuchiya H; Seino Y; Yokokawa T; Iida N; Kumahara Y
    Nephron; 1985; 40(3):286-91. PubMed ID: 3839293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.
    Stewart ZA; Blackford A; Somervell H; Friedman K; Garrett-Mayer E; Dackiw AP; Zeiger MA
    Surgery; 2005 Dec; 138(6):1018-25; discussion 1025-6. PubMed ID: 16360386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency.
    Amin H; Wall BM; Cooke CR
    Am J Med Sci; 2007 Jan; 333(1):58-62. PubMed ID: 17220696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism.
    Hulter HN; Halloran BP; Toto RD; Peterson JC
    J Clin Invest; 1985 Aug; 76(2):695-702. PubMed ID: 3928683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin.
    Charhon SA; Chapuy MC; Delvin EE; Meunier PJ
    Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease.
    Dibble JB; Sheridan P; Hampshire R; Hardy GJ; Losowsky MS
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):373-83. PubMed ID: 6274546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D, secondary hyperparathyroidism, and preeclampsia.
    Scholl TO; Chen X; Stein TP
    Am J Clin Nutr; 2013 Sep; 98(3):787-93. PubMed ID: 23885046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and the parathyroid.
    Beckerman P; Silver J
    Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D in Chronic Kidney Disease and Dialysis Patients.
    Jean G; Souberbielle JC; Chazot C
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
    Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.